Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study.
Pierre GourdyPatrice DarmonIsabelle BorgetCorinne EmeryIsabelle BureauBruno DetournayAmar BahloulNoemie AllaliAymeric MahieuAlfred PenfornisPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Use of Gla-300 resulted in a better persistence, less acute hospitalized events at least in T2DM, and reduced healthcare expenditure. These real-life results confirmed the potential interest of using Gla-300 rather than Gla-100.
Keyphrases
- healthcare
- end stage renal disease
- type diabetes
- ejection fraction
- chronic kidney disease
- newly diagnosed
- cardiovascular disease
- peritoneal dialysis
- liver failure
- glycemic control
- prognostic factors
- metabolic syndrome
- intensive care unit
- respiratory failure
- risk assessment
- skeletal muscle
- adipose tissue
- insulin resistance
- social media